ENTPD7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.727800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.145200E-01
Normal-vs-Stage2
5.184800E-01
Normal-vs-Stage3
9.281400E-01
Normal-vs-Stage4
2.704200E-01
Stage1-vs-Stage2
5.522000E-01
Stage1-vs-Stage3
8.955400E-01
Stage1-vs-Stage4
2.758600E-01
Stage2-vs-Stage3
5.318200E-01
Stage2-vs-Stage4
5.249400E-01
Stage3-vs-Stage4
3.068400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.250400E-01
Normal-vs-AfricanAmerican
2.783400E-01
Normal-vs-Asian
5.950400E-01
Caucasian-vs-AfricanAmerican
2.166200E-01
Caucasian-vs-Asian
9.886600E-01
AfricanAmerican-vs-Asian
2.341200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.937200E-01
Normal-vs-Female
5.420000E-01
Male-vs-Female
8.853200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.026600E-01
Normal-vs-Age(41-60Yrs)
3.776800E-01
Normal-vs-Age(61-80Yrs)
6.704800E-01
Normal-vs-Age(81-100Yrs)
9.780600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.374200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.453800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.405400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.678500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.010580E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.404000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.267000E-01
Normal-vs-Daily Drinker
7.929000E-01
Normal-vs-Weekly Drinker
4.208400E-01
Normal-vs-Occasional Drinker
6.294200E-01
Normal-vs-Social Drinker
5.065000E-01
Non Drinker-vs-Daily Drinker
4.259000E-01
Non Drinker-vs-Weekly Drinker
9.737700E-02
Non Drinker-vs-Occasional Drinker
2.926600E-01
Non Drinker-vs-Social Drinker
1.814220E-01
Daily Drinker-vs-Weekly Drinker
4.271600E-02
Daily Drinker-vs-Occasional Drinker
1.352020E-01
Daily Drinker-vs-Social Drinker
9.306100E-02
Weekly Drinker-vs-Occasional Drinker
6.589000E-01
Weekly Drinker-vs-Social Drinker
8.046000E-01
Occasional Drinker-vs-Social Drinker
5.363200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.974000E-01
Normal-vs-Grade 2
9.763800E-02
Normal-vs-Grade 3
1.525360E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.812200E-02
Grade 1-vs-Grade 3
1.716440E-01
Grade 1-vs-Grade 4
2.974000E-01
Grade 2-vs-Grade 3
6.512200E-01
Grade 2-vs-Grade 4
9.763800E-02
Grade 3-vs-Grade 4
1.525360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.452000E-01
Normal-vs-NonDiabetic
6.602800E-01
Diabetic-vs-NonDiabetic
8.714200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.151400E-01
Normal-vs-NoPancreatitis
6.361200E-01
Pancreatitis-vs-NoPancreatitis
6.926000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.087000E-01
Normal-vs-N1
4.929600E-01
N0-vs-N1
4.898000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.326400E-01
Normal-vs-TP53-NonMutant
7.183600E-01
TP53-Mutant-vs-TP53-NonMutant
9.719000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
